Αρχική World News Detection of ctDNA fractions with a single tumour-informed and tumour-agnostic profiling assay... World News Detection of ctDNA fractions with a single tumour-informed and tumour-agnostic profiling assay strongly predicts relapse in lung cancer Από Ogkologos - 27 Οκτωβρίου, 2026 130 0 Facebook Twitter Google+ Pinterest WhatsApp Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Will This Cancer Metastasize? Check Its “Stickiness” 6 Μαΐου, 2025 Easing Concerns about Giving Research Study Participants Their Genetic Test Results 1 Ιουνίου, 2018 A recipe for hydration! 7 Αυγούστου, 2020 Five Questions with…Debra. 31 Μαρτίου, 2022 Φόρτωση περισσοτέρων HOT NEWS Foodie Fridays: Apple Bok Choy Salad Socioeconomic Deprivation Associated with Worse Survival in Patients with Cancer Included... Coping With War and Cancer: How to Take Care of Your... EMA Recommends Additional Extensions of Indications for Pembrolizumab